BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33634022)

  • 1. A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary Carcinoma.
    Xu Y; Ma X; Ai X; Gao J; Liang Y; Zhang Q; Ma T; Mao K; Zheng Q; Wang S; Jiao Y; Zhang X; Li H
    Front Oncol; 2020; 10():597486. PubMed ID: 33634022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Cellular DNA Point Mutation and Methylation for Identifying Upper Tract Urinary Carcinoma.
    Ouyang W; Luo L; Zhang J; Xu R; Lu Q; Xu Z; Liu J; Li P; Zhang Y; Zhou C; Tang W; Wang Z; Cao M; Xu G; Wang L
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples.
    Pierconti F; Martini M; Fiorentino V; Cenci T; Racioppi M; Foschi N; Di Gianfrancesco L; Sacco E; Rossi E; Larocca LM; Bassi PF
    Hum Pathol; 2021 Dec; 118():42-48. PubMed ID: 34582934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis.
    Fujimoto M; Arai E; Tsumura K; Yotani T; Yamada Y; Takahashi Y; Maeshima AM; Fujimoto H; Yoshida T; Kanai Y
    Epigenetics; 2020 Dec; 15(12):1289-1301. PubMed ID: 32498593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
    Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
    Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale Prospective Validation Study of a Multiplex RNA Urine Test for Noninvasive Detection of Upper Tract Urothelial Carcinoma.
    Zhang H; Xu Y; Wang K; Zheng C; Li Y; Gong H; Liu C; Sheng M; Xu Q; Sun Y; Chen J; Zhang X; Zhang C; Zhang H; Wang W
    Eur Urol Oncol; 2024 Mar; ():. PubMed ID: 38523018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.
    Monteiro-Reis S; Leça L; Almeida M; Antunes L; Monteiro P; Dias PC; Morais A; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2014 Jan; 50(1):226-33. PubMed ID: 24100025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
    Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
    Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.
    Hayashi Y; Fujita K; Matsuzaki K; Matsushita M; Kawamura N; Koh Y; Nakano K; Wang C; Ishizuya Y; Yamamoto Y; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Uemura M; Imamura R; Takao T; Takada S; Netto GJ; Nonomura N
    Cancer Sci; 2019 May; 110(5):1771-1779. PubMed ID: 30887605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of upper tract urothelial carcinoma-a comparative study of urinary cytology and surgical biopsy.
    Wang L; Pambuccian SE; Wojcik EM; Barkan GA
    J Am Soc Cytopathol; 2015; 4(1):3-9. PubMed ID: 31051670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cytology with acridine orange fluorescence is highly valuable for predicting high-grade upper urinary tract urothelial carcinoma.
    Li J; Zhang Z; Wang J; Zhang C; Li H; Xu Y
    Int J Clin Exp Pathol; 2014; 7(2):774-8. PubMed ID: 24551302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic role of urine cytology and ureteroscopic biopsies in detection of high grade upper tract urothelial carcinoma.
    Zhao Y; Deng FM; Melamed J; Huang WC; Huang H; Ren Q
    Am J Clin Exp Urol; 2021; 9(3):221-228. PubMed ID: 34327261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical, ureteroscopic and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art review for the yearly scientific report of the French National Association of Urology].
    Nison L; Bozzini G; Rouprêt M; Traxer O; Colin P
    Prog Urol; 2014 Nov; 24(15):977-86. PubMed ID: 25199724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.
    Kodama H; Yoneyama T; Tanaka T; Noro D; Tobisawa Y; Yamamoto H; Suto S; Hatakeyama S; Mori K; Yoneyama T; Hashimoto Y; Kakizaki I; Nakaji S; Ohyama C
    Cancer Med; 2021 Feb; 10(4):1297-1313. PubMed ID: 33455069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.
    van Kessel KE; Van Neste L; Lurkin I; Zwarthoff EC; Van Criekinge W
    J Urol; 2016 Mar; 195(3):601-7. PubMed ID: 26327355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study.
    Freund JE; Liem EIML; Savci-Heijink CD; de Reijke TM
    Med Oncol; 2018 Nov; 36(1):10. PubMed ID: 30499061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma.
    Asai S; Fukumoto T; Tanji N; Miura N; Miyagawa M; Nishimura K; Yanagihara Y; Shirato A; Miyauchi Y; Kikugawa T; Yokoyama M
    Int J Clin Oncol; 2015 Oct; 20(5):1042-7. PubMed ID: 25794920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.